APPLICATION
ANDA091221
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
None (Tentative Approval)
Products
PREGABALINNone (Tentative Approval)
PREGABALIN 300MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 200MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 100MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 50MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 225MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 150MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 75MG · CAPSULE · ORAL
PREGABALINNone (Tentative Approval)
PREGABALIN 25MG · CAPSULE · ORAL
Approval history
2015-04-27OriginalTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.